We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Orthofix Medical Inc (OFIX) USD0.1

Sell:$14.89 Buy:$14.90 Change: $0.02 (0.13%)
Market closed |  Prices as at close on 24 May 2024 | Switch to live prices |
Change: $0.02 (0.13%)
Market closed |  Prices as at close on 24 May 2024 | Switch to live prices |
Change: $0.02 (0.13%)
Market closed |  Prices as at close on 24 May 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions specifically related to limb reconstruction and deformity correction unrelated to the spine. Global Orthopedics distributes its products globally through a network of distributors and sales representatives to sell orthopedic products to hospitals and healthcare providers. It has a portfolio of biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions, and surgical navigation system. Its products are distributed in 68 countries globally via the Company's sales representatives and distributors.

Contact details

3451 Plano Pkwy
United States
+1 (214) 9372000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$558.81 million
Shares in issue:
37.53 million
Health Care Equipment
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Massimo Calafiore
    President, Chief Executive Officer
  • Julie Andrews
    Chief Financial Officer
  • Kimberley Elting
    President - Global Orthopedics
  • Kevin Kenny
    President - Global Spine
  • Jason Shallenberger
    President - Bone Growth Therapies
  • Lucas Vitale
    Chief People and Business Operations Officer
  • Andres Cedron
    Chief Legal Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.